53.01
price up icon6.55%   3.26
 
loading

Cytokinetics Inc Aktie (CYTK) Neueste Nachrichten

pulisher
04:25 AM

Cytokinetics (CYTK) Rockets 40.45% as Aficamten Results Promising - MSN

04:25 AM
pulisher
Sep 06, 2025

Will earnings trigger a reversal in Cytokinetics Incorporated2025 Key Highlights & Smart Swing Trading Alerts - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Multi asset correlation models including Cytokinetics Incorporated2025 Price Action Summary & Detailed Earnings Play Alerts - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Is Cytokinetics Incorporated’s ROE strong enough2025 Market Outlook & Daily Growth Stock Tips - خودرو بانک

Sep 06, 2025
pulisher
Sep 06, 2025

What’s the analyst consensus on Cytokinetics Incorporated2025 Key Highlights & AI Driven Price Predictions - خودرو بانک

Sep 06, 2025
pulisher
Sep 05, 2025

Is Cytokinetics Incorporated stock a good pick for beginners2025 Sector Review & Smart Money Movement Tracker - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Published on: 2025-09-05 22:58:57 - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Is Cytokinetics Incorporated a top pick in the sectorDip Buying & Weekly Return Optimization Alerts - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Braveheart licenses Hengrui's heart drug HRS-1893 in $1B deal - BioWorld MedTech

Sep 05, 2025
pulisher
Sep 05, 2025

Is Cytokinetics Incorporated stock bottoming outTrade Signal Summary & Safe Capital Allocation Plans - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Cytokinetics patents new MYBPC2 inhibitors - BioWorld MedTech

Sep 05, 2025
pulisher
Sep 05, 2025

Cytokinetics shares rise 1.19% premarket after Cantor Global Healthcare Conference fireside chat. - AInvest

Sep 05, 2025
pulisher
Sep 05, 2025

Predicting Cytokinetics Incorporated trend using moving averagesJuly 2025 Patterns & Safe Entry Momentum Tips - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Real time social sentiment graph for Cytokinetics IncorporatedMarket Movement Recap & AI Powered Market Entry Strategies - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Updated: Hengrui does another US deal, this time in Cytokinetics' cardio arena - Endpoints News

Sep 05, 2025
pulisher
Sep 04, 2025

Using Python tools to backtest Cytokinetics Incorporated strategiesJuly 2025 Sector Moves & Weekly Market Pulse Updates - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Spinal Muscular Atrophy Market Positioned for Accelerated - openPR.com

Sep 04, 2025
pulisher
Sep 04, 2025

Will Cytokinetics Incorporated benefit from macro trendsQuarterly Trade Report & Technical Pattern Recognition Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Cytokinetics Incorporated stock prediction for this weekJuly 2025 PreEarnings & Consistent Profit Trading Strategies - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

How to read the order book for Cytokinetics Incorporated2025 Short Interest & Community Consensus Picks - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

How to manage a losing position in Cytokinetics IncorporatedJuly 2025 News Drivers & Proven Capital Preservation Tips - Newser

Sep 04, 2025
pulisher
Sep 03, 2025

Movement Recap: Is Cytokinetics Incorporated a top pick in the sector2025 Trading Volume Trends & AI Based Trade Execution Alerts - خودرو بانک

Sep 03, 2025
pulisher
Sep 03, 2025

Cytokinetics Gains on Positive Late-Stage Cardiomyopathy Study Results - Yahoo Finance

Sep 03, 2025
pulisher
Sep 03, 2025

Cytokinetics: Evercore ISI Group raises PT to $80 from $60, maintains Outperform. - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Cytokinetics shares fall 1.15% premarket after insider sold shares worth $337,800. - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Will Cytokinetics Incorporated benefit from rate cutsInsider Selling & Risk Controlled Stock Alerts - خودرو بانک

Sep 03, 2025
pulisher
Sep 03, 2025

Understanding Cytokinetics Incorporated’s price movement2025 Biggest Moves & Community Trade Idea Sharing Platform - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Does Cytokinetics Incorporated show high probability of reboundJuly 2025 PostEarnings & Long Hold Capital Preservation Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can Cytokinetics Incorporated recover in the next quarterMarket Rally & Free Safe Capital Growth Stock Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Applying chart zones and confluence areas to Cytokinetics Incorporated2025 Year in Review & Growth Oriented Trade Recommendations - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What’s next for Cytokinetics Incorporated stock pricePortfolio Profit Report & Long-Term Growth Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Technical signs of recovery in Cytokinetics IncorporatedMarket Sentiment Summary & Safe Entry Zone Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Detecting support and resistance levels for Cytokinetics IncorporatedChart Signals & High Win Rate Trade Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How high can Cytokinetics Incorporated stock goJuly 2025 Macro Moves & Long-Term Growth Stock Strategies - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Cytokinetics’ Aficamten with breakthrough Phase III results - European Biotechnology Magazine

Sep 02, 2025
pulisher
Sep 02, 2025

Cytokinetics Shares Jump 40.45% on Aficamten HCM Data $630M Volume Ranks 162nd - AInvest

Sep 02, 2025
pulisher
Sep 02, 2025

Is Cytokinetics Incorporated on track to beat earnings2025 Key Highlights & Smart Swing Trading Techniques - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

Stifel raises Cytokinetics stock price target to $96 on bullish outlook - Investing.com Canada

Sep 02, 2025
pulisher
Sep 02, 2025

Should I buy Cytokinetics Incorporated stock nowIPO Watch & Daily Profit Maximizing Trade Tips - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Cytokinetics’ Aficamten Shows Head-To-Head Advantage Vs. Beta Blockers - insights.citeline.com

Sep 02, 2025
pulisher
Sep 02, 2025

Growth or Bubble? Decoding Cytokinetics’ Surge - timothysykes.com

Sep 02, 2025
pulisher
Sep 02, 2025

These Stocks Moved the Most Today: Nvidia, PepsiCo, Tesla, Kraft Heinz, Constellation Brands, Cytokinetics, and More - Barron's

Sep 02, 2025
pulisher
Sep 02, 2025

Cytokinetics at Citi’s Biopharma Conference: Aficamten’s Promising Path - Investing.com

Sep 02, 2025
pulisher
Sep 02, 2025

Cytokinetics Skyrockets On 'Provocative' Results In Heart Disease - Investor's Business Daily

Sep 02, 2025
pulisher
Sep 02, 2025

Aficamten Bests Metoprolol in Cytokinetics' Trial for Obstructive Hypertrophic Cardiomyopathy - PharmTech

Sep 02, 2025
pulisher
Sep 02, 2025

Bitcoin gains, Frontier upgraded, Cytokinetics trial results - Yahoo Finance

Sep 02, 2025
pulisher
Sep 02, 2025

Cytokinetics: Game-Changing Data Confirms Best-In-Class Potential (NASDAQ:CYTK) - Seeking Alpha

Sep 02, 2025
pulisher
Sep 02, 2025

Cytokinetics says heart disease drug more effective than standard-of-care, shares jump - TradingView

Sep 02, 2025
pulisher
Sep 02, 2025

Cytokinetics’ Aficamten: Navigating Regulatory Hurdles and Market Potential in the OHCM Space - AInvest

Sep 02, 2025
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):